Zealand Pharma’s CSO leaves the company

The company announces that Andrew Parker will leave his position as Executive Vice President and Chief Scientific Officer. Andrew Parker has accepted a top executive leadership position in a non-competing biotechnology company outside Denmark. “I have thoroughly enjoyed my time at Zealand Pharma, contributing to an exceptional growth story over the last few years and … Continue reading Zealand Pharma’s CSO leaves the company